World's first malaria vaccine approved for use in children in Africa

This is an historic moment. The first ever malaria vaccine for children has been approved in sub-Saharan Africa. Tedros Adhanom Ghebreyesus (director general of the World Health Organization) stated in a statement that the long-awaited vaccine against malaria for children is a breakthrough in science, child health, and malaria control.
Malaria is caused by a parasite that is spread through the bites from infected mosquitoes. It causes more than 400,000 deaths each year in sub-Saharan Africa. People use insecticide-treated nets to prevent spread and drug treatments.

RTS,S, or Mosquirix is a vaccine that contains a portion of the parasite protein bound to a part of the hepatitis B protein. This allows immune cells to recognize the substance. It is available in four doses starting at 5 months old.

Bruce MacQueen/Alamy transmit malaria to humans through mosquitoes.

Advertisement

The WHO stated yesterday that trials have shown that the vaccine can reduce the number of cases of deadly or severe malaria by 30% even in areas with widespread use of bed nets. This is less effective than vaccines for other diseases, such as the 60-90% effectiveness of some covid-19 vaccinations against severe illness.

In the latest trials, it was also shown that bed nets were still used by families who had their children immunized.

Nanthalile Mugala, an international non-profit organisation working for malaria development, said that approving the vaccine for general use will increase equity in access to malaria prevention.

Learn how to boost your immunity system with our online immunology course.